Parma, Italy

Fabio Rancati

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: Innovations by Fabio Rancati: Contributions to Rho-Kinase Inhibition

Introduction

Fabio Rancati, an esteemed inventor located in Parma, Italy, has made significant strides in the pharmaceutical field with a total of 19 patents to his name. His innovative work focuses primarily on developing compounds that target Rho-Kinase (ROCK) enzymes, which are implicated in various pulmonary disorders.

Latest Patents

Among his latest patents is the invention titled "Meta tyrosine derivatives as Rho-kinase inhibitors." This groundbreaking invention relates to compounds that inhibit Rho Kinase and are specifically meta tyrosine derivatives. The patent details processes for preparing these compounds, pharmaceutical compositions containing them, and their therapeutic uses. Notably, the compounds may hold promise for treating conditions like asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and pulmonary arterial hypertension (PAH).

Another remarkable innovation by Fabio is titled "Oxadiazole derivatives as Rho-Kinase Inhibitors." Similar to his previous work, this invention addresses compounds derived from oxidazole that inhibit Rho Kinase. It outlines methods for synthesizing these compounds and their potential therapeutic applications in treating pulmonary diseases linked to ROCK enzymes.

Career Highlights

Fabio Rancati's career at Chiesi Farmaceutici S.p.A. highlights his dedication to advancing pharmaceutical research and development. His extensive work in innovation has positioned him as a leading figure in the field of drug discovery and development. The contributions he has made through his patents are not only innovative but also essential in addressing critical health challenges.

Collaborations

Throughout his career, Fabio has collaborated closely with accomplished professionals in the industry, including Ian Linney and Andrea Rizzi. These partnerships have fostered a dynamic approach to research and have significantly contributed to the success of his innovations.

Conclusion

Fabio Rancati's inventive spirit and commitment to addressing complex health issues through targeted therapeutic agents have significantly impacted the pharmaceutical landscape. His 19 patents underscore a legacy of innovation that will continue influencing the treatment of pulmonary disorders and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…